AUSTRALIAN JOURNAL OF BIOMEDICAL RESEARCH
Review Article
Aug 11, 2026 4 3

Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine

Toyin Tolulope Lawal 1 * ,
James Momoh 2,
Michael Kayode Odedele 3,
Casmir Mmaduabuchi Okonkwo 4
1 Department of Biochemistry, Ladoke Akintola University of Technology Ogbomosho, Oyo State, Nigeria2 Department of Information Systems, College of Business and Information Systems, Dakota State University, Madison, SD, USA3 Department of Kinesiology, College of Health, Human Services & Nursing, California State University, Dominguez Hills, Carson, CA, USA4 Department of Medical Laboratory Science, Imo State University, Owerri, Imo State, Nigeria* Corresponding Author
Australian Journal of Biomedical Research, 2(3), 2026, aubm025, https://doi.org/10.63946/aubiomed/19130
Publication date: Aug 11, 2026
Full Text (PDF)

ABSTRACT

The human microbiome functions as a metabolically active organ whose biochemical output is continuously integrated with host physiology. Conventional microbiome surveys, built largely on taxonomic profiling, capture community composition and diversity but resolve neither the functional capacity of these communities nor the bidirectional metabolic exchange that links them to the host. A central limitation is that taxonomy is a poor proxy for function: phylogenetically distinct organisms can perform equivalent reactions, and closely related taxa can diverge metabolically. Resolving host microbiome interactions, therefore, requires integration across heterogeneous, high-dimensional molecular layers, such as metagenomics, metatranscriptomics, proteomics, metabolomics, and host genomic and phenotypic data at a scale and complexity that exceeds classical analytical pipelines. Artificial intelligence (AI) has emerged as a complementary framework for this problem. Machine learning, deep learning, and graph-based models can integrate multi-omics data, infer latent metabolic structure, predict microbial functional potential, and model microbe-metabolite-host relationships as connected networks rather than isolated parts. These approaches have sharpened the discovery of disease-associated microbial and metabolic signatures and candidate therapeutic targets, and they underpin emerging precision medicine applications, including individualized risk stratification, biomarker discovery, and treatment response prediction. Substantial barriers remain, however, including incomplete and non-standardized reference data, limited model interpretability, vulnerability to bias and overfitting, and a shortage of prospective clinical validation. Continued progress in foundation models, real-time microbiome monitoring, and patient-specific metabolic modelling is expected to move the field from descriptive association toward predictive, preventive, and personalized clinical application. 

KEYWORDS

Artificial Intelligence Host-Microbiome Interactions Metabolic Networks Multi-Omics Integration Precision Medicine

CITATION (Vancouver)

Lawal TT, Momoh J, Odedele MK, Okonkwo CM. Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine. Australian Journal of Biomedical Research. 2026;2(3):aubm025. https://doi.org/10.63946/aubiomed/19130
APA
Lawal, T. T., Momoh, J., Odedele, M. K., & Okonkwo, C. M. (2026). Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine. Australian Journal of Biomedical Research, 2(3), aubm025. https://doi.org/10.63946/aubiomed/19130
Harvard
Lawal, T. T., Momoh, J., Odedele, M. K., and Okonkwo, C. M. (2026). Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine. Australian Journal of Biomedical Research, 2(3), aubm025. https://doi.org/10.63946/aubiomed/19130
AMA
Lawal TT, Momoh J, Odedele MK, Okonkwo CM. Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine. Australian Journal of Biomedical Research. 2026;2(3), aubm025. https://doi.org/10.63946/aubiomed/19130
Chicago
Lawal, Toyin Tolulope, James Momoh, Michael Kayode Odedele, and Casmir Mmaduabuchi Okonkwo. "Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine". Australian Journal of Biomedical Research 2026 2 no. 3 (2026): aubm025. https://doi.org/10.63946/aubiomed/19130
MLA
Lawal, Toyin Tolulope et al. "Artificial Intelligence-Driven Reconstruction of Host–Microbiome Metabolic Networks: From Multi-Omics Integration to Precision Medicine". Australian Journal of Biomedical Research, vol. 2, no. 3, 2026, aubm025. https://doi.org/10.63946/aubiomed/19130

REFERENCES

  1. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. https://doi.org/10.1186/s13073-016-0307-y
  2. Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400. https://doi.org/10.1038/nm.4517
  3. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165(6):1332–45. https://doi.org/10.1016/j.cell.2016.05.041
  4. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. https://doi.org/10.1038/s41579-020-0433-9
  5. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. https://doi.org/10.1038/nature11234
  6. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63. https://doi.org/10.1038/nature09922
  7. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic Roles of Bile Acids in Metabolism. Cell Metab. 2013;17(5):657–69. https://doi.org/10.1016/j.cmet.2013.03.013
  8. Angermueller C, Pärnamaa T, Parts L, Stegle O. Deep learning for computational biology. Mol Syst Biol. 2016;12(7):MSB156651. https://doi.org/10.15252/msb.20156651
  9. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. https://doi.org/10.1038/s41591-018-0300-7
  10. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–7. https://doi.org/10.1038/s41586-019-1291-3
  11. Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025;23(10):635–51. https://doi.org/10.1038/s41579-025-01183-w
  12. Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24(8):577–95. https://doi.org/10.1038/s41577-024-01014-8
  13. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–69. https://doi.org/10.1016/j.cmet.2013.03.013
  14. Magnúsdóttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol. 2017;35(1):81–9. https://doi.org/10.1038/nbt.3703
  15. Orth JD, Thiele I, Palsson BØ. What is flux balance analysis? Nat Biotechnol. 2010;28(3):245–8. https://doi.org/10.1038/nbt.1614
  16. Machado D, Andrejev S, Tramontano M, Patil KR. Fast automated reconstruction of genome-scale metabolic models for microbial species and communities. Nucleic Acids Res. 2018;46(15):7542–53. https://doi.org/10.1093/nar/gky537
  17. Zimmermann J, Kaleta C, Waschina S. gapseq: informed prediction of bacterial metabolic pathways and reconstruction of accurate metabolic models. Genome Biol. 2021;22(1):81. https://doi.org/10.1186/s13059-021-02295-1
  18. Magnúsdóttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol. 2017;35(1):81–9. https://doi.org/10.1038/nbt.3703
  19. Heinken A, Hertel J, Acharya G, Ravcheev DA, Nyga M, Okpala OE, et al. Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nat Biotechnol. 2023;41(9):1320–31. https://doi.org/10.1038/s41587-022-01628-0
  20. Arkin AP, Cottingham RW, Henry CS, Harris NL, Stevens RL, Maslov S, et al. KBase: The United States Department of Energy Systems Biology Knowledgebase. Nat Biotechnol. 2018;36(7):566–9. https://doi.org/10.1038/nbt.4163
  21. Diener C, Gibbons SM, Resendis-Antonio O. MICOM: Metagenome-Scale Modeling To Infer Metabolic Interactions in the Gut Microbiota. mSystems. 2020;5(1):e00606-19. https://doi.org/10.1128/msystems.00606-19
  22. Chan SHJ, Simons MN, Maranas CD. SteadyCom: Predicting microbial abundances while ensuring community stability. PLoS Comput Biol. 2017;13(5):e1005539. https://doi.org/10.1371/journal.pcbi.1005539
  23. Oh M, Zhang L. DeepMicro: deep representation learning for disease prediction based on microbiome data. Sci Rep. 2020;10(1):6026. https://doi.org/10.1038/s41598-020-63159-5
  24. Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights. PLoS Comput Biol. 2016;12(7):e1004977. https://doi.org/10.1371/journal.pcbi.1004977
  25. Przymus P, Rykaczewski K, Martín-Segura A, Truu J, Carrillo De Santa Pau E, Kolev M, et al. Deep learning in microbiome analysis: a comprehensive review of neural network models. Front Microbiol. 2025;15:1516667. https://doi.org/10.3389/fmicb.2024.1516667
  26. Morton JT, Aksenov AA, Nothias LF, Foulds JR, Quinn RA, Badri MH, et al. Learning representations of microbe–metabolite interactions. Nat Methods. 2019;16(12):1306–14. https://doi.org/10.1038/s41592-019-0616-3
  27. Wang Q, Wang K, Wu W, Giannoulatou E, Ho JWK, Li L. Host and microbiome multi-omics integration: applications and methodologies. Biophys Rev. 2019;11(1):55–65. https://doi.org/10.1007/s12551-018-0491-7
  28. Alves L de F, Westmann CA, Lovate GL, de Siqueira GMV, Borelli TC, Guazzaroni ME. Metagenomic Approaches for Understanding New Concepts in Microbial Science. Int J Genomics. 2018;2018:2312987. https://doi.org/10.1155/2018/2312987
  29. Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–8. https://doi.org/10.1038/s41592-018-0176-y
  30. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-Gut Microbiota Metabolic Interactions. Science. 2012;336(6086):1262–7. https://doi.org/10.1126/science.1223813
  31. Wilmes P, Bond PL. Metaproteomics: studying functional gene expression in microbial ecosystems. Trends Microbiol. 2006;14(2):92–7. https://doi.org/10.1016/j.tim.2005.12.006
  32. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–72. https://doi.org/10.1038/nbt.1511
  33. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human Genetics Shape the Gut Microbiome. Cell. 2014;159(4):789–99. https://doi.org/10.1016/j.cell.2014.09.053
  34. Mallick H, Franzosa EA, Mclver LJ, Banerjee S, Sirota-Madi A, Kostic AD, et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat Commun. 2019;10(1):3136. https://doi.org/10.1038/s41467-019-10927-1
  35. Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights. PLoS Comput Biol. 2016;12(7):e1004977. https://doi.org/10.1371/journal.pcbi.1004977
  36. Pan J, Zhang Z, Li Y, Yu J, You Z, Li C, et al. A microbial knowledge graph-based deep learning model for predicting candidate microbes for target hosts. Brief Bioinform. 2024;25(3):bbae119. https://doi.org/10.1093/bib/bbae119
  37. Noecker C, Eng A, Srinivasan S, Theriot CM, Young VB, Jansson JK, et al. Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation. mSystems. 2016;1(1):e00013-15. https://doi.org/10.1128/mSystems.00013-15
  38. Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–62. https://doi.org/10.1038/s41586-019-1237-9
  39. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. https://doi.org/10.1038/nature11450
  40. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. https://doi.org/10.1038/nature12198
  41. Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–89. https://doi.org/10.1038/s41591-019-0406-6
  42. Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25(4):667–78. https://doi.org/10.1038/s41591-019-0405-7
  43. Pan J, Zhang Z, Li Y, Yu J, You Z, Li C, et al. A microbial knowledge graph-based deep learning model for predicting candidate microbes for target hosts. Brief Bioinform. 2024;25(3):bbae119. https://doi.org/10.1093/bib/bbae119
  44. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016;375(24):2369–79. https://doi.org/10.1056/NEJMra1600266
  45. Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400. https://doi.org/10.1038/nm.4517
  46. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97–103. https://doi.org/10.1126/science.aan4236
  47. Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–7. https://doi.org/10.1126/science.aan3706
  48. Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104–8. https://doi.org/10.1126/science.aao3290
  49. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. https://doi.org/10.1038/nature11450
  50. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. https://doi.org/10.1038/nature12198
  51. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079–94. https://doi.org/10.1016/j.cell.2015.11.001
  52. Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623–8. https://doi.org/10.1038/nature25979
  53. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–7. https://doi.org/10.1038/s41586-019-1291-3
  54. Yilmaz B, Mooser C, Keller I, Li H, Zimmermann J, Bosshard L, et al. Long-term evolution and short-term adaptation of microbiota strains and sub-strains in mice. Cell Host Microbe. 2021;29(4):650-663.e9. https://doi.org/10.1016/j.chom.2021.02.001
  55. Leake I. Severity of NAFLD in patients who are not obese. Nat Rev Gastroenterol Hepatol. 2016;13(8):436. https://doi.org/10.1038/nrgastro.2016.114
  56. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. https://doi.org/10.1038/nature11234
  57. Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10:e65088. https://doi.org/10.7554/eLife.65088
  58. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016;375(24):2369–79. https://doi.org/10.1056/NEJMra1600266
  59. Dalla-Torre H, Gonzalez L, Mendoza-Revilla J, Lopez Carranza N, Grzywaczewski AH, Oteri F, et al. Nucleotide Transformer: building and evaluating robust foundation models for human genomics. Nat Methods. 2025;22(2):287–97. https://doi.org/10.1038/s41592-024-02523-z
  60. Ligeti B, Szepesi-Nagy I, Bodnár B, Ligeti-Nagy N, Juhász J. ProkBERT family: genomic language models for microbiome applications. Front Microbiol. 2023;14:1331233. https://doi.org/10.3389/fmicb.2023.1331233
  61. Mimee M, Nadeau P, Hayward A, Carim S, Flanagan S, Jerger L, et al. An ingestible bacterial-electronic system to monitor gastrointestinal health. Science. 2018;360(6391):915–8. https://doi.org/10.1126/science.aas9315
  62. Kalantar-Zadeh K, Berean KJ, Ha N, Chrimes AF, Xu K, Grando D, et al. A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut. Nat Electron. 2018;1(1):79–87. https://doi.org/10.1038/s41928-017-0004-x

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.